- Home
- FCT vs AQST Comparison
FCT vs AQST Comparison
Compare FCT & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FCT
- AQST
- Stock Information
- Founded
- FCT 2004
- AQST 2004
- Country
- FCT United States
- AQST United States
- Employees
- FCT N/A
- AQST N/A
- Industry
- FCT Finance Companies
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- FCT Finance
- AQST Health Care
- Exchange
- FCT Nasdaq
- AQST Nasdaq
- Market Cap
- FCT 265.0M
- AQST 274.4M
- IPO Year
- FCT N/A
- AQST 2018
- Fundamental
- Price
- FCT $10.04
- AQST $3.04
- Analyst Decision
- FCT
- AQST Strong Buy
- Analyst Count
- FCT 0
- AQST 6
- Target Price
- FCT N/A
- AQST $11.17
- AVG Volume (30 Days)
- FCT 106.8K
- AQST 1.4M
- Earning Date
- FCT 01-01-0001
- AQST 05-06-2025
- Dividend Yield
- FCT 11.29%
- AQST N/A
- EPS Growth
- FCT N/A
- AQST N/A
- EPS
- FCT N/A
- AQST N/A
- Revenue
- FCT N/A
- AQST $57,561,000.00
- Revenue This Year
- FCT N/A
- AQST N/A
- Revenue Next Year
- FCT N/A
- AQST $39.51
- P/E Ratio
- FCT N/A
- AQST N/A
- Revenue Growth
- FCT N/A
- AQST 13.79
- 52 Week Low
- FCT $9.45
- AQST $2.24
- 52 Week High
- FCT $10.42
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- FCT 30.22
- AQST 51.97
- Support Level
- FCT $10.13
- AQST $3.05
- Resistance Level
- FCT $10.30
- AQST $3.24
- Average True Range (ATR)
- FCT 0.08
- AQST 0.19
- MACD
- FCT -0.01
- AQST 0.01
- Stochastic Oscillator
- FCT 13.33
- AQST 48.53
About FCT First Trust Senior Floating Rate Income Fund II of Beneficial Interest
First Trust Senior Floating Rate Income Fund II is the United States based diversified, closed-end management investment company. Its investment objective is to seek a high level of current income. As a secondary objective, the fund attempts to preserve capital. The fund seeks to achieve the objectives by investing in a portfolio of senior floating-rate loan interests. Its portfolio of investments consists of aerospace and defense, agricultural products, broadcasting, cable and satellite, electric utilities and other sectors.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Sympazan Oral Film, Suboxone Sublingual Film, Exservan Oral Film, and Zuplenz. The product pipeline includes Libervant Buccal Film, AQST-108, and AQST-305. The majority of its revenue comes from the United States.